Sometimes, being early makes all the difference.

Yesterday, Iovance Biotherapeutics, Inc. (IOVA) was added to the PRO Quant Portfolio (PQP).

Today, it surged +30%.*

The stock surged after Iovance raised its 2026 revenue outlook.

IOVA is a powerful example of why timing matters. By the time a stock makes a major move, the opportunity to get positioned before it may already be gone.

PQP is built around our top-rated stocks, with the model portfolio adjusted every week as new opportunities emerge. With typically 30 positions, it’s designed to move quickly when the next opportunity appears.

And it’s not just about one stock. Over the past six months, the PRO Quant Portfolio has returned 20.95%, compared to 12.14% for the S&P 500 Equal Weight.**

IOVA is the latest example of what PQP can identify before a major move. The bigger question is: what will it find next?

Right now, you can put PRO to work for just $99 for your first month.*** You’ll unlock in-depth analysis, weekly portfolio updates, and complete performance tracking for PQP—plus Premium’s full suite of research tools, Top Analyst Ideas, and more. 

*Iovance Biotherapeutics, Inc. (IOVA) performance is as of September 29, 2026.

**PRO Quant Portfolio and S&P 500 EWI 6-month performances are as of September 29, 2026.

***Introductory offer for the first year only. $99 will be immediately charged for a 1-month paid trial to PRO. After your 1-month paid trial to PRO, $2,400 will be automatically charged for the first year of an annual subscription to PRO unless you cancel during your paid trial. Auto-renews as an annual subscription at the then-current list price (current list price is $2,400/year) until canceled. Plus sales tax/VAT, where applicable.

Past performance is no guarantee of future results. Any content and tools on the platform are offered for informational purposes only. The PRO Quant Portfolio is not an investment product run with real money. It is not a brokerage account and neither enables nor reflects actual trading activity. No recommendation or advice is given as to whether any investment is suitable for a particular investor. You are solely responsible for determining whether any investment, security, strategy, product, or service is appropriate or suitable for you based on your investment objectives and personal and financial situation and for evaluating its benefits and risks. Any views or opinions expressed may not reflect those of Seeking Alpha as a whole. Seeking Alpha does not take account of your objectives or your financial situation and Seeking Alpha does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker, U.S. investment adviser, or investment bank. For more details on performance calculation and methodology of the PRO Quant Portfolio, click here.

Sent by Seeking Alpha, 244 5th Ave, Suite 2705, New York, NY 10001

Why are you receiving this? You subscribed to Seeking Alpha Marketing Updates.

Unsubscribe from this list | Update your email preferences